Bandingkan Harga & Kinerja Adhi Karya Persero Tbk (ADHI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Adhi Karya Persero Tbk dan Brigit Biofarmaka Teknologi Tbk.: Adhi Karya Persero Tbk diperdagangkan di Rp143 (kapitalisasi pasar 1,21 T, volume 24 jam 6,95 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: Adhi Karya Persero Tbk jauh lebih besar — sekitar 7,3× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Adhi Karya Persero Tbk lebih aktif diperdagangkan (6,95 jt vs 187,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ADHI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 1,21 T | 164,65 M |
Volume | 6,95 jt | 187,4 rb |
Lot | 69,49 rb | 1,87 rb |
Perputaran | 987,36 jt | 44,35 jt |
Harga Rata-rata | 142,08 | 236,67 |
Nilai Transaksi | 987,36 jt | 44,35 jt |
Harga Ekuilibrium Indikatif | 143 | 242 |
Volume Ekuilibrium Indikatif | 738 | 500 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Adhi Karya Persero Tbk
The name of Adhi karya for the first time was stated in Decree of the Minister of Public Works and Labor on March 11, 1960. Subsequently, based on Government Regulation No. 65 of 1961, Adhi Karya was determined as a State Owned Company Adhi Karya. In the same year, based on the same Government Regulation, a former Dutch-owned construction company that has been nationalized, Associate NV, was merged into the Company. PT Adhi Karya (Persero) Tbk was established on Jun 1, 1974.
Selengkapnya di halaman ADHI →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
